Community support may improve chances of African-American smokers quitting
-->
Trusting neighbors and community may aid smoking cessation in African-American smokers, accordingly to a study published in the Annals of Behavioral Medicine, a publication of the Society of Behavioral Medicine.
MD Anderson researchers collected data from 397 African-Americans seeking...
Three new therapies increase options for CML and some ALL patients
Patients with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia that carries the Philadelphia chromosome (Ph+ALL) who can't tolerate...
Three new therapies increase options for CML patients
Path-breaking targeted therapies have extended the lives of people with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia that...
Melanoma faculty contribute to Nature Medicine's 2012 top advances
By Leslie Loddeke, Publications Coordinator, Melanoma Medical Oncology Department
MD Anderson Melanoma Medical Oncology Chair Patrick Hwu, M.D., and Professor Wen-Jen Hwu, M.D., Ph.D., were coauthors of one of the papers named in Nature Medicine's "Notable advances 2012" list of the year's top basic biomedical discoveries.
The article notes "certain areas of biomedicine saw fast-paced...
Ibrutinib is best 'single-agent ever tested in mantle cell lymphoma'
An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable...
Umbilical cord blood stem cells build new blood supply faster after lab expansion
-->
A new technique for expanding blood stem cells from umbilical cords in the lab before transplanting them into a patient reduces...
Clinical trials show benefit for lymphoma patients @ASH
A drug approved for treating resistant versions of two types of lymphoma knocked down the disease in all 26 patients evaluated in a phase...
Day two @ASH: Phase 2 clinical trial results for new CML drug, FDA okays it today
Updated: 4:30 p.m. Friday, Dec. 14
The U.S. Food and Drug Administration approved ponatinib (Iclusig) for chronic myeloid leukemia...
Day one: MD Anderson @ American Society of Hematology
Elnar Koseoglu of Physician Relations and Bradley Swinney of Banner MD Anderson await the afternoon rush at booth 3500 in the exhibition hall...
MD Anderson physician receives award for decades of accomplishments
Fifty years from now when an author is compiling a review of modern cancer therapy for a historical publication, he'll undoubtedly recognize...
MD Anderson research makes ASCO Clinical Cancer Advances for 2012
Two papers published by MD Anderson clinical researchers are included in the American Society of Clinical Oncology's report, Clinical Cancer...
MD Anderson scientists, physicians voted into elite group
Updated Dec. 3, 2012
MD Anderson has six new Fellows in the American Association for the Advancement of Science, elected by their peers...
Protein feeds brain tumors' sugar habit, new drug blocks it
A protein that sneaks into the cell nucleus and sets off two separate cancer-promoting processes vital to the development of malignant brain...
Racial disparities: An unexplained factor in kidney cancer survival
A grimmer prognosis awaits African-Americans when compared to Caucasian patients suffering from renal cell carcinoma (RCC), the most common...
Molecular details provide new answer for heart-threatening chemotherapy
An effective drug that kills cancer by damaging DNA also attacks heart muscle, which for some patients leads to...
Depression, telomere length double-team bladder cancer patients
According to data from the National Cancer Institute's SEER database, less than 50% of patients with stage three bladder cancer will survive...
Routine blood test predicts risk of developing liver cancer
A simple measure of liver function routinely taken via blood tests at physical exams and other doctor's visits turns out to be highly predictive...
AACR: An annual meeting of "like minds" in cancer prevention
One of the most collaborative meetings of researchers in basic, clinical, behavioral and epidemiological science focused on cancer prevention...
Institute of Medicine elects Lynda Chin to membership
Lynda Chin, M.D., professor and chair of MD Anderson's Department of Genomic Medicine and scientific director of the Institute for Applied...
Making a difference in the lives of women with rare ovarian cancers
The Holy Grail of oncology is personalized cancer therapy. While patients with either malignant ovarian germ cell tumors or ovarian sex cord-stromal...
New approach to attacking cancer: Find out what's gone and exploit it
When missing segments of the genome matter in cancer, it's bad news because those deletions have wiped out a gene that blocks or hinders cancer...
Leprosy bacterium accounts for most, worst cases in Mexico
In 2008, MD Anderson Professor of Laboratory Medicine Xiang-Yang Han, M.D., Ph.D., and colleagues discovered the second species of bacterium...
Adopt a secret identity, recruit allies, and slay YOUR cancer!
I grew up playing games with my friends. I wanted to play any kind of physical game (sports), or board games (Stratego, Monopoly, Battleship...
Blend of imaging, treatments allows removal of "inoperable" pancreatic cancer
A select number of high-risk pancreatic cancer patients initially deemed inoperable are, in fact, eligible for surgery and have a chance for...
Researchers develop tool to predict benefit of radiation therapy
During the next two decades, breast cancer diagnoses in older women are expected to increase by 57%. It's a reality that highlights the importance...
"Grab2" grip on growth factor receptor guides crucial signaling
The protein Grb2, once considered merely a passive link between other proteins, acts as an on-off switch for a critical growth signaling pathway...
Intact tumor suppressor hinders one type of breast cancer chemotherapy
A gene most commonly known as a tumor-suppressor appears to help breast cancer cells survive treatment by a common chemotherapy drug.
<...New drugs being discussed at the Annual American Society of Clinical Oncology (ASCO)
The Annual American Society of Clinical Oncology (ASCO) meeting will be discussing several new drugs in development. We have been investigating...
Drug shrinks melanoma metastases in the brain
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients...
New course added to professional oncology education site
MD Anderson has launched a new course on The Professional Oncology Education site. Colorectal Cancer Survivorship is funded by a grant from...
Cell surface protein reveals and imperils breast cancer stem cells
Cancer stem cells, a small subgroup of hard-core tumor cells capable of both self-renewal and tumor generation, are hard to find, let alone...
Prostate Cancer Stem Cells Emerge from Low-PSA Cells
While discussion continues over the value of screening healthy men for prostate cancer by testing for levels of prostate specific antigen...
Runners, Walkers Join Research Journey for Ovarian Cancer Cures
When 3,000 participants lineup Saturday for the 15th annual Sprint for Life 5K Run/Walk and Sprint for Sprouts Kids' Run they'll take thousands...
Study Finds Pain Relief Treatment Slightly Improves Over 20 Years
More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive appropriate...
Researchers Find Potential Drug for Preventing, Treating Radiation Sickness
An antibody created at MD Anderson blocks the life-threatening gastrointestinal damage caused by high levels of radiation - so far in mice...
Evidence Backs BRAF Inhibitor, Immunotherapy for Advanced Melanoma
Patrick Hwu, M.D., head of MD Anderson's Department of Melanoma Medical Oncology, presented evidence supporting the combination of BRAF inhibitors...
Guang Peng Wins Landon Foundation - AACR INNOVATOR Award
A creative plan to identify new drugs to prevent cancer has earned an MD Anderson scientist a prominent national award to support her research...
Breast Cancer Vaccine Activates Immune System in Clinical Trial
A vaccine that targets the HER2 protein has triggered immune responses among patients in a phase II clinical trial to prevent recurrence of...
Teaming Up Two Drugs Helps Ewing's Sarcoma Patients
A combination of two targeted therapies reduces tumors in treatment-resistant Ewing's sarcoma, a bone cancer that mainly strikes children,...
Changes in 4 Proteins Could Guide New Approaches to Breast Cancer
Abnormal activation or production of four proteins involved in translation, the final step of creating other proteins, are associated with...
AACR Awards Pasqualini Caring for Carcinoid Grant at Annual Meeting
An innovative approach to targeting the blood vessels that support neuroendocrine tumors of the pancreas has earned the support of a major...
AACR Honors Mendelsohn for 'Extraordinary Achievements'
The American Association for Cancer Research will present its sixth annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements...
Low Dose Aspirin And Cancer Risk
We have known for the past two decades that aspirin and non-steroidal anti-inflammatory drug (NSAID) use reduces the risk of colorectal and...
Molecular Networks Engage in Harmful Talk; Two Drugs Interrupt
Researchers have caught two molecular signaling networks engaged in "crosstalk" that undermines attempts to successfully target cancer-promoting...
Smoking Decline During 25-Year Period Saves Nearly 800,000 Lives
Tobacco use has long been known to cause lung cancer and increased morbidity in smokers. A study sponsored by the National Cancer Institute...
Research Seeks Factors that Keep Mexican-American Adolescents Active
At an early age, children are naturally physically active, full of energy and often find joy in running and jumping in an unstructured environment...
Drug Improves Quality of Life, Extends Survival for Myelofibrosis
Myelofibrosis, a lethal bone marrow malignancy, comes with especially debilitating symptoms that sap a patient's quality of life.
...
MD Anderson Brings World Together to Share SUMO and Ubiquitin Discoveries
The Sixth International Conference on SUMO, Ubiquitin, UBL Proteins: Implications for Human Diseases was held at the Dan Duncan building...
Progress in Pain Relief Research, Inspired by the Children
About 20 years ago, I started medical practice with no intention of pursuing research.
As the most junior person, I was asked to take...
High Platelets = Lowered Survival for Ovarian Cancer Patients
It started with a clinical observation: Why do so many ovarian cancer patients have such high levels of circulating platelets? As it turns...
Grad Student's Stunning Image Captures Expanded Cancer Cell and an Award
University of Texas MD Anderson Cancer Center graduate student Geoffrey Grandjean's image of ovarian cancer cells is visually striking, scientifically...
Radiation Exposure Study in Mice Hints at Cause for Testicular Cancer
The incidence of testicular cancer has increased steadily in recent years, but the cause has been elusive. MD Anderson Cancer Center scientists...
Discover's top 2011 stories include new melanoma therapy
Read between the lines and you'll find an MD Anderson Cancer Center connection to one of Discover's top 100 stories of 2011, announced in...
MD Anderson Experts Review Leukemia, Lymphoma, Multiple Myeloma Progress
Andrew Schorr is a pioneer in health communications and patient education and, along the way, became a patient himself. Andrew was diagnosed...
MD Anderson Melanoma Researchers Identify Predictive Genetic Clues
A study led by Melanoma Medical Oncology Department researcher Michael A. Davies, M.D., Ph.D., published in the journal Cancer identifies...
Genetic Analysis Shows Promise as Predictor of Need for Chemotherapy
A new 14-gene assay shows promise as a predictor of which early stage lung cancer patients may need chemotherapy because their disease is...
Research Uncovers a Potential Weak Link in the Kras Chain
Kras, an influential gene that serves as an on-off switch for other genes, is mutated in 80 to 95% of cases of pancreatic cancer.
"...
Inflammation Silences Tumor-Fighting Genes in Colorectal Cancer
Chronic inflammation and the chemical silencing of tumor-suppressing genes have long been known to influence development and progression of...